Lyme disease
Lyme disease is a natural epidemic disease caused by Borrelia burgdorferi, also known as Lyme borreliosis. The early stage of the disease is often characterized by chronic migratory erythema. The clinical manifestations are mainly multi-system and multi-organ damage such as skin, heart, nerves and joints. In 1975, the disease occurred in large numbers among children in Lyme, Connecticut, USA, hence the name.
-
Site of disease:
whole body -
Infectious :
Contagious -
Frequent population:
People of different ages are generally susceptible to this disease... -
Related symptoms:
Itch Joint pain Papules Joint swelling Headache -
Concurrent disease:
Related Drugs
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Shaanxi Dunsi Pharmaceutical Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Shaanxi Dunsi Pharmaceutical Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Youcare Pharmaceutical Group Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Chongqing KERUI Pharmaceutical (GROUP) Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
China National Medicines Guorui Pharmaceutical Co., Ltd.
Ceftriaxone Sodium for Injection
Indication: Infections caused by pathogens sensitive to Rocephin, such as: sepsis, meningitis, disseminated Lyme disease (early and late stages), abdominal infections (peritonitis, biliary and gastrointestinal infections), bone, joint, soft tissue, skin and wound infections, infections in immunocompromised patients, kidney and urinary tract infections, respiratory tract infections, especially pneumonia, ear, nose and throat infections, reproductive system infections, including gonorrhea, and preoperative prevention of infection.
Manufacturer:
Shaanxi Dunsi Pharmaceutical Co., Ltd.
Related Ingredients